ACIU

MKT CAP:$250M

AC Immune Ltd

Market Cap

$250M

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Healthcare·Biotechnology·🇺🇸·NASDAQ

Stock Price

$2.25-$1.11 (-33.04%)

Jun 5, 2026

52W High $3.9952W Low $1.83

Company Details

AC Immune SA, a clinical stage biopharmaceutical company, discovers, designs, and develops medicines, and therapeutic and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding....

CEO

—

IPO Date

Sep 23, 2016

Website

www.acimmune.com

Key Metrics TTM (CHF)

Revenue

CHF 4M

-86.9% YoY

Net Income

-CHF 66M

EPS (Diluted)

Free Cash Flow

-CHF 51M

Revenue / Share

CHF 0.04

Gross Margin

100.0%

Operating Margin

-1749.0%

Net Margin

-1788.8%

FCF Margin

-1375.6%

P/S

P/E

Earnings Reports

Q1 2026

Apr 23, 2026

CHF 1M+13.0%

FY 2025

Mar 13, 2026

CHF 4M-86.9%

Q4 2025

Mar 13, 2026

CHF 338.0K-70.3%

Q3 2025

Nov 4, 2025

CHF 939.0K-96.3%

Q2 2025

Aug 5, 2025

CHF 1M+90.1%

Revenue & Profitability (CHF)

Operating Cash Flow (CHF)

CapEx Spend (CHF)

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation (CHF)

OpEx Breakdown (CHF)

War Chest (CHF)

Shares Outstanding

Revenue Per Employee (CHF)

Revenue / Employee